ClearPoint Neuro (CLPT) Share-based Compensation Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.29% |
| Dec 31, 2025 | 43.29% |
| Sep 30, 2025 | 47.16% |
| Jun 30, 2025 | 56.59% |
| Mar 31, 2025 | 52.94% |
| Dec 31, 2024 | 50.17% |
| Sep 30, 2024 | 54.05% |
| Jun 30, 2024 | 54.50% |
| Mar 31, 2024 | 58.03% |
| Dec 31, 2023 | 42.47% |
| Sep 30, 2023 | 50.06% |
| Jun 30, 2023 | 42.18% |
| Mar 31, 2023 | 39.49% |
| Sep 30, 2021 | 19.74% |
| Jun 30, 2021 | 0.72% |
| Mar 31, 2021 | 10.74% |
| Sep 30, 2020 | 1.73% |
| Jun 30, 2020 | -20.82% |
| Mar 31, 2020 | -9.61% |
| Dec 31, 2019 | 43.29% |
| Sep 30, 2019 | 2.71% |
| Jun 30, 2019 | 2.07% |
| Mar 31, 2019 | -3.22% |
| Dec 31, 2018 | -27.98% |
| Sep 30, 2018 | -9.64% |
| Jun 30, 2018 | -2.67% |
| Mar 31, 2018 | -4.92% |
| Sep 30, 2016 | -0.85% |
| Jun 30, 2016 | -1.26% |
| Mar 31, 2016 | -5.48% |